Prostate cancer drug degarelix tested for Long-Term safety
NCT ID NCT00117286
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at the long-term safety of the drug degarelix in 57 men with prostate cancer. Participants received a monthly injection of degarelix for up to 5 years. The goal was to monitor side effects, such as changes in blood pressure, pulse, weight, and liver function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Degarelix (a hormone-blocking drug given as a monthly injection)
What this could lead to
If successful, this could confirm that long-term use of degarelix is safe for controlling prostate cancer.
What could go wrong
This is an extension study focused on safety, not on how well the drug works. The small number of participants (57) limits how much we can learn about rare side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Urology Medical Center
Anaheim, California, 92801, United States
-
Brantford Urology Research
Brantford, Ontario, N3R4N3, Canada
-
Burlington Professional Care
Burlington, Ontario, L7N3V2, Canada
-
Can-Med Clinical Research, Inc.
Victoria, British Columbia, V8T5G1, Canada
-
Investigational site
Seattle, Washington, 98166, United States
-
Lawrenceville Urology
Lawrenceville, New Jersey, 08648, United States
-
Northeast Indiana Research, LLC
Fort Wayne, Indiana, 46825, United States
-
Regional Urology
Shreveport, Louisiana, 71106, United States
-
SW Florida Urological Associates
Fort Myers, Florida, 33907, United States
-
South Florida Medical Research
Aventura, Florida, 33180, United States
-
State College Urologic Association
State College, Pennsylvania, 16801, United States
-
The Female/Male Health Centres
Oakville, Ontario, L6H3P1, Canada
-
The Male and Female Health and Research Centers
Barrie, Ontario, L4M7G1, Canada
-
The Urology Center
Greensboro, North Carolina, 27401, United States
-
University Urological Research Institute
Providence, Rhode Island, 02904, United States
-
University of Vermont, Dept of Surgery
South Burlington, Vermont, 05403, United States
-
Urology Associate PC'
Denver, Colorado, 80210, United States
-
Urology Centers of Alabama
Homewood, Alabama, 35209, United States
-
Urology San Antonio Research
San Antonio, Texas, 78229, United States
-
Virginia Urology Center
Richmond, Virginia, 23235, United States
-
West Coast Clinical Research
Tarzana, California, 91356, United States
-
Western Clinical Research
Torrance, California, 90505, United States